English
中文简体
Oligosaccharides
What are HMOs Why choose us HMOs products Online Message
Position：Home · Oligosaccharides · What are HMOs
Human Milk Oligosaccharides

Human Milk Oligosaccharides (HMOs) are the third largest solid component in breast milk (after fat and lactose), with functions such as regulating immunity, helping brain development, and regulating gut microbiota. They are known as the "soft gold" of breast milk. The average content of HMOs in human colostrum is 20.9g/L, which is 10-100 times higher than other mammalian milk. Its rarity and unique nutritional value make it a "noble" in the dairy industry, making milk powder products infinitely close to breast milk standards and almost becoming the ultimate goal of all infant and toddler dairy companies.

Scientists have found that there are over 200 different monomers of HMOs in breast milk, which are formed by five monosaccharides extending their sugar chains or undergoing fucosylation and sialylation on the basis of their core structure. The most important ones are six: 2 '- FL (2' - halophilic lactose), 3-FL (3-halophilic lactose), LNT (lacto-N-tetraose), LNnT (lacto-N-tetraose), 3 '- SL (3' - sialyllactulose), and 6 '- SL (6' - sialyllactulose). The diversity of combinations of different monosaccharide structures endows HMOs with various excellent functions.

ab1.png
Improve intestinal health
70% of the baby's immune system exists in the intestine, and HMOs are not easily digested and absorbed by the upper digestive tract. Most of them can reach the distal small and large intestine intact, serving as substrates for beneficial bacteria such as bifidobacteria, promoting the growth of probiotics, while also inhibiting the growth of harmful bacteria such as E. coli and Clostridium perfringens, and providing nutrition and energy for colon cells
ab2.png
Boost immunity
70% of the baby's immune system exists in the intestine, and HMOs are not easily digested and absorbed by the upper digestive tract. Most of them can reach the distal small and large intestine intact, serving as substrates for beneficial bacteria such as bifidobacteria, promoting the growth of probiotics, while also inhibiting the growth of harmful bacteria such as E. coli and Clostridium perfringens, and providing nutrition and energy for colon cells
ab3.png
Promote brain development
70% of the baby's immune system exists in the intestine, and HMOs are not easily digested and absorbed by the upper digestive tract. Most of them can reach the distal small and large intestine intact, serving as substrates for beneficial bacteria such as bifidobacteria, promoting the growth of probiotics, while also inhibiting the growth of harmful bacteria such as E. coli and Clostridium perfringens, and providing nutrition and energy for colon cells
ab4.png
Preventing the invasion of intestinal pathogens
70% of the baby's immune system exists in the intestine, and HMOs are not easily digested and absorbed by the upper digestive tract. Most of them can reach the distal small and large intestine intact, serving as substrates for beneficial bacteria such as bifidobacteria, promoting the growth of probiotics, while also inhibiting the growth of harmful bacteria such as E. coli and Clostridium perfringens, and providing nutrition and energy for colon cells
ab5.png
Antiviral activity
70% of the baby's immune system exists in the intestine, and HMOs are not easily digested and absorbed by the upper digestive tract. Most of them can reach the distal small and large intestine intact, serving as substrates for beneficial bacteria such as bifidobacteria, promoting the growth of probiotics, while also inhibiting the growth of harmful bacteria such as E. coli and Clostridium perfringens, and providing nutrition and energy for colon cells
On January 5, 2024, HMOs were selected as one of the "Top 10 Food Safety and Health Hotspots of 2023" by the Chinese Society for Food Science and Technology